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1 Abstract Human immunodeficiency virus infection (HIV) manifests a variety- of 
clinical features resembling systemic lupus erythrematosus (SLE), and must be 
distinguished from one another. HIV infection in SLE is rare and ~t has been 
suggested that the coexclstence of HIV infect~on may amellorate SLE act~v~ty 
We report a case of SLE compl~cated by HIV lnfectlon Dur~ng 15 weeks of 
pregnancy, her SLE act~v~ty exacerbated and was found to be co-lnfected w~th H V  
.- 
The pregnancywas terrnlnated Over 5 years of follow up, her SLE coexst~ng with HIV 
infection has been quiescent without any immunosuppressive drugs and she has not 
had any opportunistic infections from HIV infection. 
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Introduction 
Human immunodefic~ency virus infection shares 
a variety of clinical features of many organs and 
systems. Rheumatic, dermatologic, gastrointestinal, 
neurologic, hematologic and renal disorders have 
been reported' HIV infection may also present 
manifestations of autoimmune diseases including 
systemic lupus erythrematosus. HIV infection in 
SLE is rare. There have been reports suggested 
that HIV infection might attenuate SLE activity 
The imbalance of immunological states in both 
d~seases may be a factor Here we report a case 
of HIV infection in SLE wtth pregnancy. As far as 
we know this is the first reported case in Thailand. 
A case report. 
A 23-year-old Thai female presented in 
June 1992 with fever; malar rash, polyarthritis, 
alopecia and oral ulcers Initial laboratory stud~es 
revealed hematocrit of 29  010 wh~te blood count 
of 5400/mm3 with 27% lymphocyte Urinalysis 
showed protein free and no urlne sed~ment LE 
test was posit~ve, ANA positive anti DNA pos~tive 
of titer 1 2560, anti Sm positrve Cg level of 0 16 
m g / d  She was diagnosed as having system~c 
lupus erythrematosus and was treated with 
prednisolone 45 mg/day Her symptoms improved 
and prednisolone dose was gradually reduced to 
20  mg/day 
In March 1993 she developed fever and 
generalized seizure This was attributed to SLE 
The prednisolone was increased to 6 0  mg/day 
She responded well and no episode of seizure 
occurred She was followed up with o w  dose 
prednisolne 
In November 1994 after losing to follow up 
for 2 months, she was admitted with hgh fever and 
generalized edema Physical examinat~on showed 
Table 1 Laboratory manifestations of reported patient 
Date 0 6 / 9 2  0 3 / 9 3  11/94 0 2 / 9 5  06 /95  10 /95  0 1 / 9 6  0 7 / 9 6  
B.P. 
Hct O/o 
Abuminura 
BUN(mg/dl) 
Cr (mg/dl) 
Uric acid 
Albumin 
Globulin 
anti ds DNA 
AN A 
C3 
total T lymph 
CD4 
C D8 
CD4/CD8 
CD8 010 
Ueg 
10 
0 5 
5 1 
4 9 
3 7 
n d 
nd 
n d 
nd 
nd. not done 
BP 180/ 1 10 mmHg, pitting edema 4+, tenderness 
of ef t  cervical lymphnodes and enlargement of 
uterus Hematocrit was 21 %, white blood cells 
count 1 4,700/mm3, 9 4  % neutrophiles, 5% 
lymphocyte, platelet 320,000, and Coombs' test 
negative. The urine was positive 4+  for protein. 
The sediment contained 2 0  to 3 0  red cells and 
8 to1 0 white cells. Llltrasound of uterus showed 
15 weeks fetus. The test for HIV by ELlSA was 
positive. Confirmatory test by Western blot was 
also positive. CD4 count was 170. CD4/CD8 
ratio was 0.2'5. Her husband without history of 
intravenous drug use was also positive for HIV 
test. Active lupus nephritis with pregnancy was 
diagnosed. She was treated with prednisolone 6 0  
mg/day. After family counseling in the presence 
of active lupus nephritis and HIV infection, the 
therapeutic abortion was performed. The prednisoione 
was tapered to 5 mg/day in 2 months, and 
discontinued. Over 5 years of follow up, she has 
been w e  and her SLE activity has been in 
remission (table 1 ). She has not had any opportunistic 
infections from HIV. 
Discussion 
Acquired immunodeficiency syndromes 
caused by human immuriodeficiency virus (HIV) 
infection was originally described in 1981'. It is 
recognized that it is an end result of an immune 
dysfunction characterized by a loss of CD4 T 
helper cells3 and high frequency of opportunistic 
infections. Ziegler and Stites in 1986 made a 
hypothesis that HIV infection is an autoimmune 
disease directed at the immune system4. HIV 
infecton has cl~nical manifestations in many organs 
and has many clinical features that are similar to 
autoimmune diseases such as rheumatoid arthritis, 
Reiter's syndrome, vasculitis, and systemic lupus 
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erythrematosus5 HIV ~nfect~on a d SLE share many 
clinical, ,serologic features, and renal pathoog~es~, 
so they must be distinguished from one another 
Both HIV infection and SLE are characterized 
by immune dysreguat~on and autoantibody 
production. The common immunological features 
of HIV infection and SLE are summarized in table 2. 
In HIV infection, antinuclear antibod~es (ANA) may 
be positive in titer of 1 :20 to 1 : 1 60, but anti DNA 
antibodies and anti Sm are not f ound7 .~he  
presence of antinuclear antibodies may contribute 
to polyclonal B cell activation, and dlffuse 
hypergammaglobulinemia in HIV infection patient8 
Table 2 lmmunologica features in ADS and SLE 
Common features in AIDS and SLE 
1 .  B cell activation . 
2. lncreased immune complexes 
3,  lncreased levels of Ij 2-microglobulin 
4.. Acid labile a interferon production 
5. Decreased autologous MLR 
6. Decreased lymphokine production ( I l l .  IL2) 
7. Decreased NK activity 
8. Viral etiology 
9. Lymphopenia 
10. Lymphocytotoxic antibodies 
1 1 .  Decreased response to mitogens 
12. Skin test anergy 
13. Natural autoantibody production 
14. Multiple organ involvement 
Differences between AIDS and SLE 
1 .  CD8 T lymphocyte 
- Relative increase In AlDS 
(decreased CD4/CD8 rato j  
- Decreased number and function 
in SLE 
2. CD4 T lymphocyte 
- Depleted in AlDS 
- Normal or depleted In SLE 
~ - 
Table 3 Cases of human immunodeficiency virus infection in systemic lupus erythrematosus 
Author Number Age Sex First Risk factor Renal pathology 
of (year) diagnosis 
patient 
Adult cases 
Kopelman R G ~  
Furie RA" 
Yeh CK" 
Bambery P ' ~  
Molina J F ' ~  
Maradona JA'" 
Lu 1 1 6  
Byrd V M ' ~  
Contreras G" 
f SLE 
m SLE 
f SLE 
m SLE 
f SLE 
m SLE 
m SLE 
f SLE 
f HIV 
f SLE 
m SLE 
f HIV 
m 
Kudva Y C ' ~  1 39 m HIV 
Cimmino MA'' 1 22 m SLE 
Fernandez-Miranda c2' 1 35  f SLE 
FOX RA" 1 30  f SLE 
Chang B G ' ~  2 32 f SLE 
27 m HIV 
Reported case 1 23  f SLE 
Pediatric cases 
Strauss JZ4 2 2 1 / 2  m HIV 
3 1 / 1 2  m HIV 
D'Agat~ vZ5 1 2 1 / 2  m HIV 
Chang B G ' ~  2 10 m HtV 
5 f HIV 
Renal transplantat~on 
IVDU 
Heterosexual 
IVDU 
Blood transfuslon 
Blood transfuson 
Homosexual 
Heterosexual 
IVDU 
Heterosexual 
Unknown 
Heterosexual 
Heterosexual 
Homosexual 
IVDU 
Heterosexual 
Heterosexual 
Unknown 
Homosexual 
Heterosexual 
Congenital HIV 
Congenital HIV 
Congenital HIV 
Congenital HIV 
Congenital HIV 
LN type V 
IN D 
ND 
ND 
ND 
ND 
IN D 
ND 
ND 
ND 
ND 
LIU type IV 
Collaspsing focal 
scleros~s (HIV) 
LN type V 
U D 
ND 
ND 
LN type IV HIVAN 
LN type IV 
ND 
?lLN type Ilb 
LN type I l l  
LN type V 
LN type I l l ,  V 
LIU type V, HVAN 
m: male, f: female, IVDU: intravenous drug use, ND: not done. LN: lupus nephritis. 
HIVAN: HIV associated nephropaty 
SLE also has false posltlve results In HIV test by pathogenesis of SLE" by ~mpurltres In the 
ELlSA technique and lndetermlnate result by antigenrc preparation used In ELlSA or Western 
Western blot testg They may result from cross blot test, and by production of antlbodes due to 
reac t~v~ ty  of retrovlral partlcle whlch make polyclonal ant~bodles stlrnulat~on such as In HIV 
poss~b~l~ty of a retrovirus as a causative agent In lnfectlon 
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Concurrent HIV infection and SLE IS rare 
only 19 cases ~n adults7 and 5 cases in 
c h i ~ d r e n ~ ~ - ' ~  have been reported in the literature 
(table 3) The rare co-incidence of HIV infection 
and SLE may be epidem~ologic as SLE occurs 
predominantly in female whereas HIV infection 
occurs in male The immunolog~c disturbances from 
HIV infection that may attenuate the clinical 
manifestation of SLE or SLE may be protection of 
HIV infectionz6 make less co-incidence of both 
diseases There were 12 males and 13 females 
including this reported case Ages of patients were 
between 2 5 to 44  years Thirteen patients were 
diagnosis as having SLE before being infected 
w~th  HIV Furie" and ~ o l i n a ' ~  described the 
improvement of SLE when infected wlth HIV The 
clinical and serologic features were improved when 
CD4 T lymphocyte decreased and SLE was flare 
when CD4 increased by azathymldine treatment 
They suggested that improvement of SLE might 
be due to CD4 depletion and supported the role 
of CD4 In the pathogenesis of SLE'~ 
Our patient fulfilled the ARA crrterla for 
diagnosis of SLE" She had periodic flare of SLE 
despite belng treated with prednisolone before 
complicated by HIV infection Her pregnancy was 
considered to be the cause of SLE flare Pregnancy 
i7ay increase SLE exacerbation in 20-50%'~ 
 id pione to develop preec~amps~a30 Low C3 
level and anti DNA antibody help to differentiate 
SLE exacerbation and preeclamps~a~~ C3 level 
nc~eases in normal pregnancy Failure of C3 
level to rise or decreased C3 level has been 
associated with SLE exacerbation3' and increases 
risk of abortion3' CD4 decreases during normal 
pregnancy33 and turns to be normal level after 
delivery Pregnancy can also accelerate HIV 
induced CD4 depletion increases risk of  
opportunistic infection and increases mortality34 
32 
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After therapeut~c aoortion and discontinuing all 
immunosuppressive drugs her symptoms of SLE 
ameliorated Her SLE and HIV infection has been 
quiescent for 5 years of follow up CD4 lymphocyte 
was rising and hlgher than that when her SLE 
exacerbated CD8 and CD8 percentage Increased 
It was different from reports from Furie and Molina 
The mechanism that attenuated SLE progression 
may be from CD4T lymphocyte dysfunction 
before CD4 depletion or from increased CD8 and 
rlcreased CD8 percentage caused by HIV infection 
- 
which may support the role of decreased CD8 
number and function in the pathogenesis of SLE~ '  
Though T cell abnormalities are important 
in the pathogenesis of SLE however the immune 
mechanisms that occur in SLE are multiple complex 
and unclear Other immunological mechanisms 
includ~ng inappropriate induction of cytokines 
system36 may play role Transforming growth 
f a c t o r - p ( ~ ~ F - P )  has immunoregulatory 
properties to enhance monocyte f u n c t ~ o n ~ ~  and
to suppress both T and B cell proliferation and 
f u n c t ~ o r l ~ ~  Mice that lacked TGF-P produce 
SLE-like autoant~bodies~~ and die of an autoimmune 
like So TGF-P may play role in suppressing 
actlvity of SLE Ohtsuka found that lymphocytes 
from SLE patients produced less TGF-b and 
interleukin 2(IL-2) than normal control and 
spontaneous IgG production was suppressed by 
adding TGF-IJ and I L - ~ ~ '  4' Monthly intramuscular 
injection of cDNA encoding TGF-P gene decreased 
IgG product~on and increased survival I murlne 
S L E ~ ~  Plasma TGF-P Increased in HIV infection 
patients44 and may suppress autoantlbodies in 
SLE but may lead to extracellular matrix deposition 
and f ~ b r o s i s ~ ~  Future investigations are needed 
to elucidate the pathogenesis of this phenomenon 
and prov~de insight into pathogenesis and 
treatment of SLE 
Conclusion 
We report a case of coexisting HIV infection 
n SLE with pregnancy Clinical improvement of SLE 
was observed when complicated by HIV infection, 
with low CD4, high CD8, and high CD8 percentage. 
lmmunological regulatory defects other than CD4 
depletion may play role to ameliorate SLE activity 
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